NCT04956133 IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment
| NCT ID | NCT04956133 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2022-08-03 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2022-08-03 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Physical activity can enhance well-being among youth diagnosed with oncological or hematological diseases. We developed a tailored, 1:1, online physical activity program (i.e., IMPACT), to promote physical activity in this cohort. The proposed single-group, mixed-methods project will assess the effect of IMPACT and explore markers of implementation.
Eligibility Criteria
Inclusion Criteria: 1. Children or adolescents between the ages of 5-18 years at enrollment and at least one parent (defined as a caregiver; biological or otherwise) 2. Diagnosed with any oncological and/or hematological diagnosis 3. Currently receiving or scheduled to receive any treatment for any oncological and/or hematological diagnosis or completed treatment \<3 months Exclusion Criteria: 1. Completed all treatment for their oncological or hematological diagnosis \>3 months 2. Unable to participate in physical activity as assessed by the patients' healthcare team or physical activity specialist 3. Parent and/or patient cannot understand verbal English 4. Parent is unwilling to be present (i.e., at home, in the same room depending on participant age and functional ability) during the physical activity sessions (required to ensure safety of the child/adolescent)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04956133 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04956133 currently recruiting?
Yes, NCT04956133 is actively recruiting participants. Contact the research team at nculosre@ucalgary.ca for enrollment information.
Where is the NCT04956133 trial being conducted?
This trial is being conducted at Calgary, Canada, Edmonton, Canada.
Who is sponsoring the NCT04956133 clinical trial?
NCT04956133 is sponsored by University of Calgary. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.